Meta Information
ID:epitalon
Name:
Schema Version:AIM-2.0
Interactions
Target id:
/condition/active-cancer
Target name:
Active Cancer or High Cancer Risk
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Epitalon activates telomerase, an enzyme that lengthens telomeres. While this is a target for anti-aging, it is also a mechanism that cancer cells use to achieve immortality and proliferate.
Actionable advice:
Avoid completely if you have an active malignancy or a strong personal or family history of cancer.
Target id:
/condition/pregnancy
Target name:
Pregnancy
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
The effects of this research peptide on fetal development are completely unknown and it has not been studied in pregnant individuals.
Actionable advice:
Avoid completely during pregnancy due to unknown risks to the fetus.
Target id:
/condition/lactation
Target name:
Breastfeeding (Lactation)
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
It is unknown if Epitalon or its metabolites are excreted in breast milk or what their potential effects on a nursing infant might be.
Actionable advice:
Avoid completely while breastfeeding due to unknown risks to the infant.
Target id:
/condition/pediatric
Target name:
Pediatric
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
The safety, efficacy, and long-term effects of Epitalon on growth and development have not been established in children or adolescents.
Actionable advice:
Do not administer to individuals under the age of 18.
Target id:
/procedure/oral-administration
Target name:
Oral Administration (Swallowing)
Severity:
major
Interaction type:
diminishing
Nature:
absolute
Temporal spacing:
null
Description:
As a peptide, Epitalon is rapidly degraded by digestive enzymes in the gastrointestinal tract, which breaks it down and prevents any systemic absorption or effect.
Actionable advice:
Never take Epitalon orally; it must be administered via injection or a properly formulated nasal spray to be effective.
Target id:
/class/immunosuppressants
Target name:
Immunosuppressant Medications
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Epitalon has been shown to modulate the immune system, particularly T-cell function. This immunostimulatory effect could theoretically counteract the intended action of immunosuppressive drugs.
Actionable advice:
Avoid using Epitalon if you are taking immunosuppressants for an autoimmune condition or organ transplant.
Target id:
/class/estrogens
Target name:
Estrogens and Progestins (Hormonal Therapy & Contraceptives)
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Some research suggests Epitalon can influence the hypothalamic-pituitary-gonadal axis, potentially altering levels of gonadotropins (LH, FSH) and interfering with the efficacy of hormonal therapies.
Actionable advice:
Consult a healthcare provider before use, as it may theoretically alter the effects of hormonal medications.
Target id:
/intervention/dasatinib-quercetin
Target name:
Senolytics (Dasatinib + Quercetin)
Severity:
moderate
Interaction type:
diminishing
Nature:
absolute
Temporal spacing:
null
Description:
Epitalon's primary mechanism of activating telomerase promotes cell survival and longevity, which is mechanistically opposite to the goal of senolytics, which is to clear senescent (aged) cells.
Actionable advice:
Do not use Epitalon concurrently with senolytic therapy cycles to avoid opposing biological signals.
Target id:
/circadian/sleep
Target name:
Going to Sleep
Severity:
moderate
Interaction type:
synergistic
Nature:
temporal
Temporal spacing:
Hours before target:
1
Hours after target:
null
Description:
Epitalon is believed to regulate pineal gland function and normalize melatonin rhythms. Administering it before sleep aligns with the body's natural circadian cycle for melatonin production.
Actionable advice:
Administer the dose approximately 1 hour before your intended bedtime for optimal effect.
Target id:
/intervention/melatonin
Target name:
Melatonin
Severity:
minor
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Since Epitalon may normalize the body's own melatonin production, taking additional melatonin could lead to excessive drowsiness or potentially disrupt the natural rhythm Epitalon aims to restore.
Actionable advice:
Use with caution; consider reducing or pausing exogenous melatonin while on an Epitalon cycle.
Target id:
/class/bioactive-peptides
Target name:
Other Bioactive Peptides
Severity:
minor
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
The safety and pharmacological interactions of combining multiple research peptides are largely unknown. Concurrent use could lead to unpredictable synergistic, additive, or antagonistic effects.
Actionable advice:
Avoid combining with other peptides (e.g., BPC-157, TB-500) unless under expert medical supervision due to a lack of safety data.
Target id:
/class/live-vaccines
Target name:
Live Attenuated Vaccines
Severity:
minor
Interaction type:
adverse
Nature:
temporal
Temporal spacing:
Hours before target:
72
Hours after target:
336
Description:
Because Epitalon may modulate immune system activity, it could theoretically alter the body's intended immunological response to a live attenuated vaccine.
Actionable advice:
As a precaution, avoid using Epitalon for at least 3 days before and 2 weeks after receiving a live vaccine.